Susan Bolin, Wayne R Buck, Yan Sun, Donna Strasburg, Paige Ebert, DeAnne Stolarik, Yue-Ting Wang, Natalie Bratcher-Petersen, Sarah Clark
{"title":"丁丙诺啡缓释和速释制剂在不同品系和性别小鼠体内的药动学和注射部位损伤评价。","authors":"Susan Bolin, Wayne R Buck, Yan Sun, Donna Strasburg, Paige Ebert, DeAnne Stolarik, Yue-Ting Wang, Natalie Bratcher-Petersen, Sarah Clark","doi":"10.30802/AALAS-JAALAS-25-011","DOIUrl":null,"url":null,"abstract":"<p><p>Buprenorphine is a commonly used analgesic in laboratory rodents for procedures of moderate to severe pain. We evaluated the pharmacokinetic properties of an immediate-release formulation of buprenorphine (Bup-IR) and an extended-release formulation (Bup-ER) in both sexes of 4 different strains of mice (C57BL/6, CD-1, BALB/c, and CB17 SCID) commonly used for dermatology and oncology research at our institution. Skin at the injection site was evaluated for 7 days postinoculation and scored for reactions and then collected for histopathologic analyses. Body weights were evaluated at 1 and 4 days postinoculation. We hypothesized that the administration of Bup-ER would provide a longer duration of blood drug concentration (>1 ng/mL; minimum analgesia threshold) compared with single-dose Bup-IR. We analyzed the standard dose for Bup-IR (0.3 mg/kg) and for Bup-ER (1 mg/kg), along with saline vehicle with blood collected at 1, 4, 24, 48, 72, and 96 hours following administration of Bup-ER and 0.25, 0.5, 1, 2, 3, 6, 9, 12, and 24 hours following administration of Bup-IR using MS. Bup-ER and Bup-IR levels were consistent among sexes of a given strain but varied between strains. Skin reactions, body weight loss, and histopathologic changes were greater in the Bup-ER-treated mice with some sex and strain differences. Due to changes found on histopathology of the skin sections taken from the injection site for Bup-ER-inoculated mice, a separate study to determine cytokine release following Bup-ER injection was performed and revealed only minor changes in a few cytokines. In conclusion, Bup-ER provided longer duration analgesia (>1 ng/mL) compared with Bup-IR. Based on differences found in the strains of mice evaluated, we recommend performing pharmacokinetic analyses for a given strain to determine the best dosing frequency and dose of buprenorphine (IR or ER) for procedures that require analgesia.</p>","PeriodicalId":94111,"journal":{"name":"Journal of the American Association for Laboratory Animal Science : JAALAS","volume":" ","pages":"1-12"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of Extended- and Immediate-Release Buprenorphine Formulations on Pharmacokinetics and Injection Site Lesions in Different Strains and Sex of Mice.\",\"authors\":\"Susan Bolin, Wayne R Buck, Yan Sun, Donna Strasburg, Paige Ebert, DeAnne Stolarik, Yue-Ting Wang, Natalie Bratcher-Petersen, Sarah Clark\",\"doi\":\"10.30802/AALAS-JAALAS-25-011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Buprenorphine is a commonly used analgesic in laboratory rodents for procedures of moderate to severe pain. We evaluated the pharmacokinetic properties of an immediate-release formulation of buprenorphine (Bup-IR) and an extended-release formulation (Bup-ER) in both sexes of 4 different strains of mice (C57BL/6, CD-1, BALB/c, and CB17 SCID) commonly used for dermatology and oncology research at our institution. Skin at the injection site was evaluated for 7 days postinoculation and scored for reactions and then collected for histopathologic analyses. Body weights were evaluated at 1 and 4 days postinoculation. We hypothesized that the administration of Bup-ER would provide a longer duration of blood drug concentration (>1 ng/mL; minimum analgesia threshold) compared with single-dose Bup-IR. We analyzed the standard dose for Bup-IR (0.3 mg/kg) and for Bup-ER (1 mg/kg), along with saline vehicle with blood collected at 1, 4, 24, 48, 72, and 96 hours following administration of Bup-ER and 0.25, 0.5, 1, 2, 3, 6, 9, 12, and 24 hours following administration of Bup-IR using MS. Bup-ER and Bup-IR levels were consistent among sexes of a given strain but varied between strains. Skin reactions, body weight loss, and histopathologic changes were greater in the Bup-ER-treated mice with some sex and strain differences. Due to changes found on histopathology of the skin sections taken from the injection site for Bup-ER-inoculated mice, a separate study to determine cytokine release following Bup-ER injection was performed and revealed only minor changes in a few cytokines. In conclusion, Bup-ER provided longer duration analgesia (>1 ng/mL) compared with Bup-IR. Based on differences found in the strains of mice evaluated, we recommend performing pharmacokinetic analyses for a given strain to determine the best dosing frequency and dose of buprenorphine (IR or ER) for procedures that require analgesia.</p>\",\"PeriodicalId\":94111,\"journal\":{\"name\":\"Journal of the American Association for Laboratory Animal Science : JAALAS\",\"volume\":\" \",\"pages\":\"1-12\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American Association for Laboratory Animal Science : JAALAS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.30802/AALAS-JAALAS-25-011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Association for Laboratory Animal Science : JAALAS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30802/AALAS-JAALAS-25-011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Evaluation of Extended- and Immediate-Release Buprenorphine Formulations on Pharmacokinetics and Injection Site Lesions in Different Strains and Sex of Mice.
Buprenorphine is a commonly used analgesic in laboratory rodents for procedures of moderate to severe pain. We evaluated the pharmacokinetic properties of an immediate-release formulation of buprenorphine (Bup-IR) and an extended-release formulation (Bup-ER) in both sexes of 4 different strains of mice (C57BL/6, CD-1, BALB/c, and CB17 SCID) commonly used for dermatology and oncology research at our institution. Skin at the injection site was evaluated for 7 days postinoculation and scored for reactions and then collected for histopathologic analyses. Body weights were evaluated at 1 and 4 days postinoculation. We hypothesized that the administration of Bup-ER would provide a longer duration of blood drug concentration (>1 ng/mL; minimum analgesia threshold) compared with single-dose Bup-IR. We analyzed the standard dose for Bup-IR (0.3 mg/kg) and for Bup-ER (1 mg/kg), along with saline vehicle with blood collected at 1, 4, 24, 48, 72, and 96 hours following administration of Bup-ER and 0.25, 0.5, 1, 2, 3, 6, 9, 12, and 24 hours following administration of Bup-IR using MS. Bup-ER and Bup-IR levels were consistent among sexes of a given strain but varied between strains. Skin reactions, body weight loss, and histopathologic changes were greater in the Bup-ER-treated mice with some sex and strain differences. Due to changes found on histopathology of the skin sections taken from the injection site for Bup-ER-inoculated mice, a separate study to determine cytokine release following Bup-ER injection was performed and revealed only minor changes in a few cytokines. In conclusion, Bup-ER provided longer duration analgesia (>1 ng/mL) compared with Bup-IR. Based on differences found in the strains of mice evaluated, we recommend performing pharmacokinetic analyses for a given strain to determine the best dosing frequency and dose of buprenorphine (IR or ER) for procedures that require analgesia.